Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species
PLOS One · 2025
DOI: 10.1371/journal.pone.0323084 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Hiu-Lam Ngai und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. Hauptthemen laut MEDLINE: Isatis, Drugs, Chinese Herbal, Plants, Medicinal. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Isatidis Folium (Daqingye, DQY) and Isatidis Radix (Banlangen, BLG) are the leaf and root of the plant Isatis tinctoria Fort. (syn. Isatis indigotica Fort.), commonly prescribed for detoxification, and the inhibition of viral and oxidative activities. Given their widespread use, we set forth to investigate the authenticity and chemical composition of DQY and BLG samples obtained from eighteen administrative districts in the Hong Kong market.
Methods
The present study screened the identities and chemical composition of DQY and BLG through molecular authentication and HPLC methods, respectively. Molecular authentication utilized DNA barcoding, focusing on nuclear ribosomal and chloroplast regions. The HPLC methods were conducted in accordance with the Hong Kong Chinese Materia Medica Standards (HKCMMS).
Results
We found that only one sample was genuine according to the species definition in the Chinese Pharmacopoeia and HKCMMS for both herbs. The chemical composition of the adulterated and the genuine samples were completely different, that the adulterant samples did not have the standard chemical markers epigoitrin and indirubin of Banlangen and Daqingye as listed in the Chinese Pharmacopoeia.
Conclusion
Our investigation underscores the widespread substitution by Strobilanthes (Nanbanlangen and Nandaqingye) species, mainly due to the preference of use of this herb in southern China. The adulteration of Daqingye by Blumea balsamifera (Ainaxiang) was probably due to mislabeling in the herb shop, though the error might have originated from the supplying sources. We recommend providing education on the necessity of using authentic Daqingye and Banlangen, especially in combined regimens, to standardize treatment effects. More education is also needed on the morphological differentiation of Banlangen from Nanbanlangen and Daqingye from Nandaqingye. The implementation of a track-and-trace system is strongly recommended to prevent and deter incorrect supply chain practices that lead to substitution or adulteration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
- LDS YYC R&D Centre for Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
- Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
ORCID-Profile: Pang-Chui Shaw
Zitieren
APA
Ngai, H. L., Cheng, S. W., Tse, T. S., Lee, H. K., & Shaw, P. C. (2025). Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species. PLOS One. https://doi.org/10.1371/journal.pone.0323084
Vancouver
Ngai HL, Cheng SW, Tse TS, Lee HK, Shaw PC. Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species. PLOS One. 2025. doi:10.1371/journal.pone.0323084
BibTeX
@article{Ngai2025,
author = {Ngai, Hiu-Lam and Cheng, Sau-Wan and Tse, Tin-Sum and Lee, Hung Kay and Shaw, Pang-Chui},
title = {Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323084}
}
EUVIMED